Literature DB >> 28682004

Thermal Stimuli-Triggered Drug Release from a Biocompatible Porous Metal-Organic Framework.

Ke Jiang1, Ling Zhang1, Quan Hu2, Qi Zhang1, Wenxin Lin1, Yuanjing Cui1, Yu Yang1, Guodong Qian1.   

Abstract

Drug delivery carriers with a high drug loading capacity and biocompatibility, especially for controlled drug release, are urgently needed due to the side effects and frequently dose in the traditional therapeutic method. In our work, a Zr-based metal-organic framework named ZJU-801, which is isoreticular with NU-801, has been designed and further demonstrated as an excellent drug delivery system (DDS) with a high drug loading of 41.7 %. Such a high drug loading capacity may be ascribed to the appropriate match of the size and the large pore volume of this kind of Zr MOF material. Compared with DS@NU-801, this DDS has successfully achieved on-command heating-activated drug release, which was probably attributed to the bulkier ligand, the better stability, and the intense π-π interaction between ZJU-801 and diclofenac sodium (DS) demonstrated comprehensively by SEM, powder X-ray diffraction (PXRD), FTIR and 13 C solid-state NMR spectroscopy as well as computer simulations. It is worth noting that premature drug release was avoided effectively without any complicated post-modifications. The low cytotoxicity and good biocompatibility of our DDS were certificated by the in vitro favorable results from an MTT assay, a WST-1 assay, and confocal microscopy imaging.
© 2017 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  drug carriers; drug delivery; medicinal chemistry; metal-organic frameworks; pi-pi interactions

Mesh:

Substances:

Year:  2017        PMID: 28682004     DOI: 10.1002/chem.201701904

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  5 in total

1.  Heterostructured Bi2S3@NH2-MIL-125(Ti) nanocomposite as a bifunctional photocatalyst for Cr(vi) reduction and rhodamine B degradation under visible light.

Authors:  Minghua Wang; Longyu Yang; Jinyun Yuan; Linghao He; Yingpan Song; Hongzhong Zhang; Zhihong Zhang; Shaoming Fang
Journal:  RSC Adv       Date:  2018-04-03       Impact factor: 4.036

Review 2.  Nanoplatforms for Targeted Stimuli-Responsive Drug Delivery: A Review of Platform Materials and Stimuli-Responsive Release and Targeting Mechanisms.

Authors:  Yuzhe Sun; Edward Davis
Journal:  Nanomaterials (Basel)       Date:  2021-03-16       Impact factor: 5.076

Review 3.  Recent advances in nanosized metal organic frameworks for drug delivery and tumor therapy.

Authors:  Junlei Yang; Hui Wang; Jinyao Liu; Mengkui Ding; Xianjin Xie; Xiaoyu Yang; Yaru Peng; Shuang Zhou; Ruizhuo Ouyang; Yuqing Miao
Journal:  RSC Adv       Date:  2021-01-14       Impact factor: 3.361

4.  Functionalization of MOF-5 with mono-substituents: effects on drug delivery behavior.

Authors:  Mengru Cai; Liuying Qin; Longtai You; Yu Yao; Huimin Wu; Zhiqin Zhang; Lu Zhang; Xingbin Yin; Jian Ni
Journal:  RSC Adv       Date:  2020-10-07       Impact factor: 4.036

5.  Biocompatible Fe-Based Micropore Metal-Organic Frameworks as Sustained-Release Anticancer Drug Carriers.

Authors:  Xin Leng; Xiaoxv Dong; Wenping Wang; Na Sai; Chunjing Yang; Longtai You; Hongliang Huang; Xingbin Yin; Jian Ni
Journal:  Molecules       Date:  2018-09-28       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.